On July 11, 2023, the company has received $10,280,238 in its first tranche. The transaction included participation from 124 investors.
Centrexion Therapeutics Corporation
Equities
CNTX
US15643W1009
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+47.33% | 54.63B | |
-6.68% | 39.92B | |
+37.07% | 38.82B | |
+13.90% | 26.86B | |
-11.17% | 26.22B | |
-21.88% | 18.78B | |
+25.96% | 12.21B | |
+0.75% | 12.16B | |
+26.72% | 11.94B |